Item 5.02 |
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. |
On June 27, 2023, JOANN Inc. (the “Company”) held its 2023 Annual Meeting of Stockholders (the “Annual Meeting”). At the Annual Meeting, the stockholders of the Company approved the amendment and restatement of the JOANN Inc. 2021 Equity Incentive Plan (the “2021 Plan”). We refer to the 2021 Plan, as amended and restated, as the “Amended 2021 Plan.”
In general, the Amended 2021 Plan continues to authorize the Compensation Committee (the “Compensation Committee”) of the Board of Directors (the “Board”) of the Company to grant cash or equity-based compensation, primarily in the form of stock options, stock appreciation rights, restricted stock, restricted stock units, other stock or cash based awards and dividend equivalents, to Company non-employee directors, plus officers and other employees of the Company (or any parent of the Company or subsidiary) and certain consultants to the Company (or any parent of the Company or subsidiary). The purpose of the Amended 2021 Plan continues to be to promote the success and enhance the value of the Company by linking the individual interests of potential awardees to those of Company stockholders by providing such awardees with awards that incentivize outstanding performance to generate superior returns to Company stockholders and help the Company motivate, attract, and retain the services of potential awardees. Subject to adjustment as described in the Amended 2021 Plan and the Amended 2021 Plan’s share counting rules, a total of 10,000,000 shares of common stock, par value $0.01 per share, of the Company (“Common Stock”) (consisting of 8,000,000 new shares approved by the Company’s stockholders in 2023 and 2,000,000 shares approved by the Company’s stockholders in 2021) are available for awards granted under the Amended 2021 Plan (plus shares remaining available under certain of the Company’s prior equity plans when the 2021 Plan became effective; plus an annual increase on the first day of each calendar year beginning on January 1, 2022 and ending on and including January 1, 2031 equal to the lesser of (1) 4% of the shares outstanding on the last day of the immediately preceding fiscal year and (2) such smaller number of shares as determined by the Board (the “Evergreen Feature”)).
Company stockholder approval of the Amended 2021 Plan (1) increased the fixed number of shares of Common Stock available under the 2021 Plan by 8,000,000 shares to 10,000,000 shares (and retained the Evergreen Feature), (2) correspondingly increased the limit on shares of Common Stock that may be issued or transferred upon the exercise of incentive stock options granted under the 2021 Plan, during its duration (as described below), by 8,000,000 shares of Common Stock, (3) applied the 5% carve-out from the minimum vesting provisions to the entire available share pool (not just shares available as of the original effective date of the 2021 Plan), (4) added clarification language regarding whistleblower activities, and (5) extended the term of the 2021 Plan until the tenth anniversary of the date of stockholder approval of the Amended 2021 Plan. The Amended 2021 Plan also makes certain other conforming, clarifying or non-substantive changes to the terms of the 2021 Plan to implement the Amended 2021 Plan. The Amended 2020 Plan administrator generally will be able to amend the Amended 2021 Plan subject to Company stockholder approval and/or awardee consent in certain circumstances, as described in the Amended 2021 Plan.
This description of the Amended 2021 Plan is qualified in its entirety by reference to the full text of the Amended 2021 Plan, which is incorporated by reference as Exhibit 10.1 to this Current Report on Form 8-K.
At the Annual Meeting, the stockholders of the Company also approved certain stock option awards granted in February 2023 under the Amended 2021 Plan that were specifically contingent on both stockholder approval of such awards and stockholder approval of the Amended 2021 Plan. These contingent stock options are referred to as the “February Contingent Stock Options.”
The February Contingent Stock Options were granted to nine of the Company’s senior executive officers with a grant date of February 27, 2023, a term of ten years and an exercise price of $3.48 per share (which was the closing price of the Common Stock on the date of grant). The February Contingent Stock Options generally vest with respect to 25% of the shares subject to the award on each of the first four anniversaries of the date of grant, subject to the officer’s continued employment with JOANN. The following grants were made to the Company’s named executive officers:
|
|
|
Named Executive Officer |
|
Number of Shares of Common Stock Subject to February Contingent Stock Options |
Wade Miquelon, former President and Chief Executive Officer |
|
1,079,741 |
Matt Susz, former Executive Vice President, Chief Financial Officer |
|
N/A |
Tom Dryer, Vice President, Former Interim Chief Financial Officer |
|
N/A |
Scott Sekella, Executive Vice President, Chief Financial Officer and member of the Interim Office of the CEO |
|
258,622 |
Janet Duliga, Executive Vice President, Chief Administrative Officer |
|
418,103 |
Chris DiTullio, Executive Vice President, Chief Customer Officer and member of the Interim Office of the CEO |
|
426,723 |
Rob Will, Executive Vice President, Chief Merchandising Officer |
|
426,723 |
1